Research status of virus-related corneal endotheliitis
10.3980/j.issn.1672-5123.2020.12.12
- VernacularTitle:病毒性角膜内皮炎的研究现状
- Author:
Yan-Ling Li
1
Author Information
1. Department of Ophthalmology, the Second Hospital of Longyan City, Longyan 364000, Fujian Province, China
- Publication Type:Review
- Keywords:
virus;
corneal endotheliitis;
auxiliary diagnostic technique;
treatment
- From:
International Eye Science
2020;20(12):2074-2078
- CountryChina
- Language:Chinese
-
Abstract:
The virus-related corneal endotheliitis has diverse inducement, complex etiology, unclear pathogenesis, diverse clinical manifestations. There is no unified classification at present. Auxiliary diagnosis technology is improving constantly, loop-mediated isothermal amplification and all kinds of PCR have a certain auxiliary role in the diagnosis of this disease. But the diagnosis also mainly relys on history and clinical manifestation in clinic. Anti-viral drug and glucocorticoid are the main treatment. Virus-related corneal endotheliitis has high recurrence rate, so there is an urgent need to research new drugs and new treatment. Experiment researches of genetic engineering drugs, such as vaccines, unwinding-primers enzyme inhibitors, and chemokine receptors, bring hope to the treatment of virus-related corneal endotheliitis. The purpose of this article is to review the related research of virus-related corneal endotheliitis.
- Full text:202012012.pdf
